Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auffermann-Gretzinger, S.
Right arrow Articles by Levy, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auffermann-Gretzinger, S.
Right arrow Articles by Levy, S.
Related Collections
Right arrow Immunobiology
Right arrow Phagocytes
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 May 2001, Vol. 97, No. 10, pp. 3171-3176

IMMUNOBIOLOGY

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

Susanne Auffermann-Gretzinger, Emmet B. Keeffe, and Shoshana Levy

From the Divisions of Oncology and of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Stanford, CA.

Dendritic cells (DCs) are important for the initiation of immune responses to foreign antigens. Their antigen uptake and presentation capacities enable them to prime and activate T cells. Immature DCs capture antigens; however, they must be activated to mature before serving as efficient antigen-presenting cells. The antigen-presenting capacity of DCs can be diminished during viral infection and as a consequence of tumor formation. Chronic infection with hepatitis C virus (HCV) has been shown to affect the allostimulatory function of DCs. In this study, it is demonstrated that monocyte-derived DCs from patients with chronic HCV infection do not respond to maturation stimuli. Instead, they maintain their immature phenotype, reflected by the pattern of cell surface markers and by their continued capacity to uptake antigen. Moreover, their allostimulatory abilities are impaired compared with those of mature DCs derived from healthy donors. To investigate a possible correlation between viral clearance and this DC maturation defect, patients with resolved HCV infection after a course of antiviral therapy were studied. Results demonstrate that DCs from patients who cleared HCV behaved like DCs from healthy donors: in response to maturation stimuli, they decrease antigen uptake, up-regulate expression of appropriate surface markers, and are potent stimulators of allogeneic T cells.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GutHome page
J A Mengshol, L Golden-Mason, N Castelblanco, K A Im, S M Dillon, C C Wilson, H R Rosen, and for the Virahep-C Study Group
Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes
Gut, July 1, 2009; 58(7): 964 - 973.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Liang, R. S. Russell, N. L. Yonkers, D. McDonald, B. Rodriguez, C. V. Harding, and D. D. Anthony
Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells
J. Virol., June 1, 2009; 83(11): 5693 - 5707.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. Gehring, S. H. Gregory, P. Wintermeyer, C. Aloman, and J. R. Wands
Generation of Immune Responses against Hepatitis C Virus by Dendritic Cells Containing NS5 Protein-Coated Microparticles
Clin. Vaccine Immunol., February 1, 2009; 16(2): 163 - 171.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. Liu, A. M. Woltman, H. L. A. Janssen, and A. Boonstra
Modulation of dendritic cell function by persistent viruses
J. Leukoc. Biol., February 1, 2009; 85(2): 205 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Dolganiuc and G. Szabo
T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't
J. Leukoc. Biol., September 1, 2008; 84(3): 614 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
V. R. Cicinnati, J. Kang, G. C. Sotiropoulos, P. Hilgard, A. Frilling, C. E. Broelsch, G. Gerken, and S. Beckebaum
Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon
J. Gen. Virol., May 1, 2008; 89(5): 1243 - 1253.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Saito, M. Ait-Goughoulte, S. M. Truscott, K. Meyer, A. Blazevic, G. Abate, R. B. Ray, D. F. Hoft, and R. Ray
Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production
J. Virol., April 1, 2008; 82(7): 3320 - 3328.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Z. Tu, A. Bozorgzadeh, R. H. Pierce, J. Kurtis, I. N. Crispe, and M. S. Orloff
TLR-dependent cross talk between human Kupffer cells and NK cells
J. Exp. Med., January 21, 2008; 205(1): 233 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Shalev, H. Liu, C. Koscik, A. Bartczak, M. Javadi, K. M. Wong, A. Maknojia, W. He, M. F. Liu, J. Diao, et al.
Targeted Deletion of fgl2 Leads to Impaired Regulatory T Cell Activity and Development of Autoimmune Glomerulonephritis
J. Immunol., January 1, 2008; 180(1): 249 - 260.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. N. Waggoner, C. H. T. Hall, and Y. S. Hahn
HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production
J. Leukoc. Biol., December 1, 2007; 82(6): 1407 - 1419.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Kakazu, N. Kanno, Y. Ueno, and T. Shimosegawa
Extracellular Branched-Chain Amino Acids, Especially Valine, Regulate Maturation and Function of Monocyte-Derived Dendritic Cells
J. Immunol., November 15, 2007; 179(10): 7137 - 7146.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Decalf, S. Fernandes, R. Longman, M. Ahloulay, F. Audat, F. Lefrerre, C. M. Rice, S. Pol, and M. L. Albert
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
J. Exp. Med., October 1, 2007; 204(10): 2423 - 2437.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. G. Rodrigue-Gervais, L. Jouan, G. Beaule, D. Sauve, J. Bruneau, B. Willems, R.-P. Sekaly, and D. Lamarre
Poly(I:C) and Lipopolysaccharide Innate Sensing Functions of Circulating Human Myeloid Dendritic Cells Are Affected In Vivo in Hepatitis C Virus-Infected Patients
J. Virol., June 1, 2007; 81(11): 5537 - 5546.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. L. Yonkers, B. Rodriguez, K. A. Milkovich, R. Asaad, M. M. Lederman, P. S. Heeger, and D. D. Anthony
TLR Ligand-Dependent Activation of Naive CD4 T Cells by Plasmacytoid Dendritic Cells Is Impaired in Hepatitis C Virus Infection
J. Immunol., April 1, 2007; 178(7): 4436 - 4444.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
H. Yu, H. Huang, J. Xiang, L. A. Babiuk, and S. van Drunen Littel-van den Hurk
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
J. Gen. Virol., January 1, 2006; 87(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
W. Li, J. Li, D. L. J. Tyrrell, and B. Agrawal
Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities
J. Gen. Virol., January 1, 2006; 87(1): 61 - 72.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari
Robust hepatitis C virus infection in vitro
PNAS, June 28, 2005; 102(26): 9294 - 9299.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Barth, A. Ulsenheimer, G. R. Pape, H. M. Diepolder, M. Hoffmann, C. Neumann-Haefelin, R. Thimme, P. Henneke, R. Klein, G. Paranhos-Baccala, et al.
Uptake and presentation of hepatitis C virus-like particles by human dendritic cells
Blood, May 1, 2005; 105(9): 3605 - 3614.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Tavakoli, W. Schwerin, A. Rohwer, S. Hoffmann, S. Weyer, R. Weth, H. Meisel, H. Diepolder, M. Geissler, P. R. Galle, et al.
Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection
J. Gen. Virol., October 1, 2004; 85(10): 2829 - 2836.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Barnes, M. Salio, V. Cerundolo, J. Medlin, S. Murphy, G. Dusheiko, and P. Klenerman
Impact of Alpha Interferon and Ribavirin on the Function of Maturing Dendritic Cells
Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3382 - 3389.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. S. Ludwig, A. N. Lekkerkerker, E. Depla, F. Bosman, R. J. P. Musters, S. Depraetere, Y. van Kooyk, and T. B. H. Geijtenbeek
Hepatitis C Virus Targets DC-SIGN and L-SIGN To Escape Lysosomal Degradation
J. Virol., August 1, 2004; 78(15): 8322 - 8332.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Larsson, E. Babcock, A. Grakoui, N. Shoukry, G. Lauer, C. Rice, C. Walker, and N. Bhardwaj
Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus
J. Virol., June 15, 2004; 78(12): 6151 - 6161.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. N. Q. Pham, S. A. MacParland, P. M. Mulrooney, H. Cooksley, N. V. Naoumov, and T. I. Michalak
Hepatitis C Virus Persistence after Spontaneous or Treatment-Induced Resolution of Hepatitis C
J. Virol., June 1, 2004; 78(11): 5867 - 5874.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Laskus, M. Radkowski, J. Jablonska, K. Kibler, J. Wilkinson, D. Adair, and J. Rakela
Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages
Blood, May 15, 2004; 103(10): 3854 - 3859.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. D. Anthony, N. L. Yonkers, A. B. Post, R. Asaad, F. P. Heinzel, M. M. Lederman, P. V. Lehmann, and H. Valdez
Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection
J. Immunol., April 15, 2004; 172(8): 4907 - 4916.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. S. Longman, A. H. Talal, I. M. Jacobson, M. L. Albert, and C. M. Rice
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
Blood, February 1, 2004; 103(3): 1026 - 1029.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Radkowski, A. Bednarska, A. Horban, J. Stanczak, J. Wilkinson, D. M. Adair, M. Nowicki, J. Rakela, and T. Laskus
Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-{alpha} and interleukin 8
J. Gen. Virol., January 1, 2004; 85(1): 47 - 59.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson, S. Pascale, E. Scarselli, R. Cortese, A. Nicosia, and F.-L. Cosset
Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor
J. Biol. Chem., October 24, 2003; 278(43): 41624 - 41630.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Sarobe, J. J. Lasarte, A. Zabaleta, L. Arribillaga, A. Arina, I. Melero, F. Borras-Cuesta, and J. Prieto
Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses
J. Virol., October 15, 2003; 77(20): 10862 - 10871.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Dolganiuc, K. Kodys, A. Kopasz, C. Marshall, T. Do, L. Romics Jr., P. Mandrekar, M. Zapp, and G. Szabo
Hepatitis C Virus Core and Nonstructural Protein 3 Proteins Induce Pro- and Anti-inflammatory Cytokines and Inhibit Dendritic Cell Differentiation
J. Immunol., June 1, 2003; 170(11): 5615 - 5624.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. P. Gardner, R. J. Durso, R. R. Arrigale, G. P. Donovan, P. J. Maddon, T. Dragic, and W. C. Olson
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus
PNAS, April 15, 2003; 100(8): 4498 - 4503.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. W. Y. Chan, L. S. Kay, R. G. Khadaroo, M. W. C. Chan, S. Lakatoo, K. J. Young, L. Zhang, R. M. Gorczynski, M. Cattral, O. Rotstein, et al.
Soluble Fibrinogen-Like Protein 2/Fibroleukin Exhibits Immunosuppressive Properties: Suppressing T Cell Proliferation and Inhibiting Maturation of Bone Marrow-Derived Dendritic Cells
J. Immunol., April 15, 2003; 170(8): 4036 - 4044.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Pohlmann, J. Zhang, F. Baribaud, Z. Chen, G. J. Leslie, G. Lin, A. Granelli-Piperno, R. W. Doms, C. M. Rice, and J. A. McKeating
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
J. Virol., April 1, 2003; 77(7): 4070 - 4080.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A H Lau and A W Thomson
Dendritic cells and immune regulation in the liver
Gut, February 1, 2003; 52(2): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Jinushi, T. Takehara, T. Kanto, T. Tatsumi, V. Groh, T. Spies, T. Miyagi, T. Suzuki, Y. Sasaki, and N. Hayashi
Critical Role of MHC Class I-Related Chain A and B Expression on IFN-{alpha}-Stimulated Dendritic Cells in NK Cell Activation: Impairment in Chronic Hepatitis C Virus Infection
J. Immunol., February 1, 2003; 170(3): 1249 - 1256.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Saunier, M. Triyatni, L. Ulianich, P. Maruvada, P. Yen, and L. D. Kohn
Role of the Asialoglycoprotein Receptor in Binding and Entry of Hepatitis C Virus Structural Proteins in Cultured Human Hepatocytes
J. Virol., January 1, 2003; 77(1): 546 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Sarobe, J. J. Lasarte, N. Casares, A. Lopez-Diaz de Cerio, E. Baixeras, P. Labarga, N. Garcia, F. Borras-Cuesta, and J. Prieto
Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins
J. Virol., May 15, 2002; 76(10): 5062 - 5070.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020